Almac Clinical Technologies Signs Contracts for a Number of Large, Complex Clinical Trials

YARDLEY, PA--(Marketwire - May 21, 2008) - Almac Clinical Technologies announced today that it has signed $12m worth of new studies within the past several weeks, including one of the largest studies in the company's history. This new global mega-study will involve close to 20,000 patients and requires provision of very sophisticated technological and statistical solutions, a key strength of Almac service offering.